Cerus Corporation
CERS
#7684
Rank
A$0.65 B
Marketcap
A$3.24
Share price
-6.56%
Change (1 day)
44.36%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2026 (TTM): A$1.91 Million

According to Cerus Corporation's latest financial reports the company's current earnings are A$0.22 Billion. In 2025 the company made an earning of -A$9.87 Million, an increase over its 2024 earnings that were of -A$16.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$1.91 M-119.38%
2025 -A$9.87 Million-41.58%
2024 -A$16.89 Million-58.95%
2023 -A$41.13 Million-20.74%
2022 -A$51.89 Million-25.7%
2021 -A$69.84 Million-11.99%
2020 -A$79.36 Million-14%
2019 -A$92.28 Million21.73%
2018 -A$75.8 Million-0.65%
2017 -A$76.3 Million-10.96%
2016 -A$85.7 Million4.24%
2015 -A$82.21 Million50.99%
2014 -A$54.45 Million-10.08%
2013 -A$60.56 Million184.13%
2012 -A$21.32 Million-7.91%
2011 -A$23.15 Million
2009 -A$32.69 Million-24.69%
2008 -A$43.4 Million-25.2%
2007 -A$58.02 Million330.54%
2006 -A$13.48 Million1.49%
2005 -A$13.28 Million-61.02%
2004 -A$34.07 Million
2002 -A$84.26 Million10.02%
2001 -A$76.59 Million34.25%
2000 -A$57.05 Million61.02%
1999 -A$35.43 Million-18.81%
1998 -A$43.64 Million93.08%
1997 -A$22.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.31 B 305,369.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$18.31 M 951.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.22 B 12,987.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$23.49 Million-1,448.57%๐Ÿ‡บ๐Ÿ‡ธ USA